On February 10, 2020 MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, reported that the Company’s management will attend the following investor conferences in February (Press release, MacroGenics, FEB 10, 2020, View Source [SID1234554077]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Guggenheim Healthcare Talks 2nd Annual Oncology Day. MacroGenics’ management will participate in a fireside chat with the analyst in New York City on Thursday, February 13, 2020, at 4:00 p.m. ET.
SVB Leerink 9th Annual Global Healthcare Conference. MacroGenics’ management will participate in a fireside chat with the analyst in New York City on Wednesday, February 26, 2020, at 10:00 a.m. ET.
Webcasts of the fireside chats may be accessed under "Events & Presentations" in the Investor Relations section of MacroGenics’ website at View Source The Company will maintain archived replays of these webcasts on its website for 30 days after the conference.